Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

McGill University

$28,000.00

Nucleocytoplasmic shuttling of the stat-6 transcription factor and regulation of gene expression

FY 2011-12

Summary
Signal transducer and activator of transcription (STAT) proteins regulate cellular responses that contribute to numerous processes, both normal and pathologic, in humans and other organisms, such as fruit flies. STAT proteins function by altering the expression of specific genes in order to modify the profile of proteins that a cell expresses. STAT proteins do this by binding to DNA in the nucleus. Prior to activation, the STAT proteins are present in an inactive state in the cytoplasm of a cell. They are activated when their unique receptors are stimulated at the plasma membrane of the cell. Once activated, STAT proteins go to the nucleus in order to bind to DNA and modulate gene expression. While it was thought originally that activated STAT proteins remained in the nucleus for the duration of their activity, increasing evidence indicates that they actually stay in the nucleus only a very short time. We now know that during the course of receptor activation, STAT proteins undergo multiple rounds of activation at the plasma membrane and inactivation in the nucleus. This cycling in and out of the nucleus is thought to allow STAT proteins to translate receptor activation events at the plasma membrane into appropriate gene expression responses in the nucleus. We are investigating the mechanism by which this nucleocytoplasmic shuttling regulates the ability of a STAT family member (called STAT-6) to induce expression of genes in the nucleus. Our studies will benefit from a unique tool that we have developed to inhibit STAT-6. This is a small protein, called a peptide, which can enter cells, and bind to and inhibit STAT-6. Our preliminary data suggest that this inhibitor effectively ""traps"" activated STAT-6, preventing it from cycling between the nucleus and the cytoplasm. Thus, we will use the STAT-6 inhibitory peptide in our experiments to understand how nucleocytoplasmic shuttling of STAT-6 regulates its ability to induce expression of target genes. Our experiments will also increase our understanding of the basic mechanisms by which this family of transcription factors regulates gene expression and may ultimately lead to a better understanding of how these proteins function in both normal and pathologic cellular responses.
Program
Discovery Grants Program - Individual
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
261995-2008
Name nom
Fixman, Elizabeth
Department département
Medicine, Faculty of
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2008
Award amount
28000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
32
Committee name en
Cell Biology
Committee name fr
Biologie cellulaire
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5111
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Signal transduction
Research subject fr
Transduction de signal
Partie
4
Nb partie
5
Application title
Nucleocytoplasmic shuttling of the stat-6 transcription factor and regulation of gene expression
Keyword
NSERC
Application summary
Signal transducer and activator of transcription (STAT) proteins regulate cellular responses that contribute to numerous processes, both normal and pathologic, in humans and other organisms, such as fruit flies. STAT proteins function by altering the expression of specific genes in order to modify the profile of proteins that a cell expresses. STAT proteins do this by binding to DNA in the nucleus. Prior to activation, the STAT proteins are present in an inactive state in the cytoplasm of a cell. They are activated when their unique receptors are stimulated at the plasma membrane of the cell. Once activated, STAT proteins go to the nucleus in order to bind to DNA and modulate gene expression. While it was thought originally that activated STAT proteins remained in the nucleus for the duration of their activity, increasing evidence indicates that they actually stay in the nucleus only a very short time. We now know that during the course of receptor activation, STAT proteins undergo multiple rounds of activation at the plasma membrane and inactivation in the nucleus. This cycling in and out of the nucleus is thought to allow STAT proteins to translate receptor activation events at the plasma membrane into appropriate gene expression responses in the nucleus. We are investigating the mechanism by which this nucleocytoplasmic shuttling regulates the ability of a STAT family member (called STAT-6) to induce expression of genes in the nucleus. Our studies will benefit from a unique tool that we have developed to inhibit STAT-6. This is a small protein, called a peptide, which can enter cells, and bind to and inhibit STAT-6. Our preliminary data suggest that this inhibitor effectively ""traps"" activated STAT-6, preventing it from cycling between the nucleus and the cytoplasm. Thus, we will use the STAT-6 inhibitory peptide in our experiments to understand how nucleocytoplasmic shuttling of STAT-6 regulates its ability to induce expression of target genes. Our experiments will also increase our understanding of the basic mechanisms by which this family of transcription factors regulates gene expression and may ultimately lead to a better understanding of how these proteins function in both normal and pathologic cellular responses.